Legend Biotech Corp - COMMON STOCK (LEGN)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
367,291,225
Total 13F shares
50,104,606
Share change
+10,712,627
Total reported value
$2,335,822,768
Put/Call ratio
147%
Price per share
$46.61
Number of holders
136
Value change
+$497,850,700
Number of buys
104
Number of sells
35

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q4 2021

As of 31 Dec 2021, Legend Biotech Corp - COMMON STOCK (LEGN) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,104,606 shares. The largest 10 holders included HHLR ADVISORS, LTD., Capital International Investors, BAKER BROS. ADVISORS LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., FEDERATED HERMES, INC., CAPITAL INTERNATIONAL INC /CA/, Artisan Partners Limited Partnership, and Hudson Bay Capital Management LP. This page lists 136 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.